FindTrial
Sign In

Comparison of chloral hydrate,midazolam and dexmedetomdine for MRI sedation in Infants : a prospective randomised controlled trial.

Comparison of chloral hydrate,midazolam and dexmedetomdine for MRI sedation in Infants : a prospective randomised controlled trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014579
Enrollment
Unknown
Registered
2018-01-22
Start date
2018-01-22
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The disease which need MRI scan

Interventions

chloral hydrate:50mg/kg oral chloral hydrate
chloral hydrate plus intranasal dexmedetomidine group:25mg/kg oral chloral hydrate plus 2ug/kg intranasal dexmedetomidine
midazolam plus intranasal dexmedetomidine group:0.3mg/kg oral chloral hydrate plus 2ug/kg intranasal dexmedetomidine

Sponsors

Guangzhou Women and Children Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: Infants with ASA physical status 1 to 3, aged 0~1 years who scheduled for MRI test under sedation will be recruited.

Exclusion criteria

Exclusion criteria: Exclusion criteria includes known allergy to study drugs.

Design outcomes

Primary

MeasureTime frame
sedation success rate;—

Secondary

MeasureTime frame
onset time;wakeup time;adverse reaction;—

Countries

China

Contacts

Public ContactShe Yingjun

Guangzhou Women and Children Medical Center

yjsheh@yeah.net+86 13826012672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026